BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2020
View Archived Issues
Sosei Heptares identifies antiviral small molecules for COVID-19
Read More
iSD and Biogen establish strategic research collaboration for ISD-017 for SLE
Read More
Further positive data from phase II study of GV-1001 in Alzheimer's disease
Read More
Positive topline data from phase IIb study of ARQ-154 in scalp and body psoriasis
Read More
Ascentage receives approval for phase Ib/II studies of APG-2575 in China
Read More
Onconova files IND application with FDA for ON-123300
Read More
Positive topline data from phase II OLE study of Tesomet in hypothalamic obesity
Read More
Chinese researchers patent compounds for liver diseases
Read More
ViiV Healthcare divulges new HIV1 inhibitors
Read More
AiCuris synthesizes HBV capsid assembly inhibitors
Read More
European researchers discover new NR1I3 agonists
Read More
New antibodies for COVID-19 presented by University of Pittsburgh
Read More
OBI Pharma provides promising phase I data for OBI-833
Read More
Phase II data presented for saroglitazar in patients with PBC
Read More
BCL6 degrader works via combine and conquer strategy
Read More
Targovax reports 18-month data from phase I/II study of ONCOS-102 in mesothelioma
Read More
Late events dog gene therapy
Read More
Bad seeds get an early start in AD
Read More
Phase II interim analysis of HER-Vaxx in advanced gastric cancer shows improved OS
Read More
Treatment begins in phase II/III study of Evgen's SFX-01 for ARDS
Read More
KN-046 plus KN-026 in HER2-positive solid tumors well tolerated, shows antitumoral activity
Read More
FDA approves Zokinvy for Hutchinson-Gilford progeria syndrome and progeroid laminopathies
Read More
First cohort data from phase I study of GRAd-COV2 show immune responses
Read More
Phase I/II study of SBI-101 for severe COVID-19 begins dosing
Read More
Clazosentan reduces all-cause morbidity and mortality post-aSAH in Japanese registration trials
Read More
